Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, February 15, 2013
SGS expands its Clinical Pharmacology Unit in Antwerp, Belgium with a Viral Challenge Testing facility including a 12-bed, Biosafety Level 2-Q compliant, quarantine facility.
read more
Thursday, February 14, 2013
Welcome to Pharmaceutical Outsourcing’s redesigned newsletter! We are pleased to present you with an updated, more streamlined format that bundles the latest news, insider information and product insights for pharmaceutical development.
read more
Wednesday, February 13, 2013
Almac, leading provider of contract services to the global Pharmaceutical and Biotech industries, will play a key role in delivering industry insight on the topic of Supply Chain Management at this year’s 14th Annual CTS Europe event, taking place 26...
read more
Wednesday, February 13, 2013
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of a Supplemental New Drug ...
read more
Wednesday, February 13, 2013
Recipharm and PledPharma announce FDA approval of an IND application for Phase IIb clinical trial with PledOx, PLIANT, in the U.S. The material for PLIANT has been manufactured by Recipharm Pharmaceutical Development.
read more
Monday, February 11, 2013
Ash Stevens Inc. (ASI), a full service contract pharmaceutical manufacturer, is in the final stages of completing a multi-year, multi-million dollar expansion to its cGMP manufacturing facility in Riverview, Michigan. All construction on the project ...
read more
Monday, February 11, 2013
AMRI announced today that it has signed an exclusive license agreement with Chai Therapeutics, LLC for the development of ALB 109564(a), AMRI’s novel tubulin inhibitor compound in late Phase I testing for the treatment of cancer. This agreement ...
read more
Monday, February 11, 2013
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced the availability of GLP-qPCR Biodistribution Studies required as part of the preclinical development study package for application in First In Man (FIM) of Gene Therapy ...
read more
Thursday, February 07, 2013
Metrics Inc. has appointed Joseph E. “Joe” Cobb Jr., CPIP, as director of pharmaceutical development.
read more
Thursday, February 07, 2013
The Scientific and Regulatory Consulting business of Cardinal Health Specialty Solutions (Beckloff Associates) will provide regulatory support to the National Institutes of Health’s (NIH) Therapeutics for Rare and Neglected Diseases (TRND) program ...
read more
Tuesday, February 05, 2013
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has agreed, subject to certain closing conditions, to acquire the Clinical Trial Services ...
read more
Tuesday, February 05, 2013
Pharmatek, a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has purchased another Xcelodose® 600S system. This acquisition doubles the company's manufacturing production rate for ...
read more
Friday, February 01, 2013
Metrics Inc. has appointed Joe Cascone as senior director of operations.
In his new role at Metrics, Cascone will manage the company’s commercial drug product manufacturing and packaging capabilities. He also is responsible for facility-related ...
read more
Friday, February 01, 2013
Patheon Inc., a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, today announced plans for additional investment in its Milton Park facility. Located in Oxfordshire, UK, Milton ...
read more
Wednesday, January 30, 2013
Marken today announced the expansion of its internal regulatory and technical expertise with the promotion of Dan Bell to Vice President. The announcement follows an industry-led panel discussion hosted by Marken in Farmingdale, New York on January ...
read more